Both in R&D — Physical & Biological Sciences
IQVIA Holdings vs Incyte Genomics
Over the past year IQV returned +49.9% and INCY returned +48.8%; their daily moves had a correlation of 0.37.
IQV +49.9% INCY +48.8%Growth of $1, one year, split-adjusted
| Metric | IQV | INCY |
|---|---|---|
| Price | $270.97 | $124.82 |
| Market cap | $44.60B | $25.30B |
| Today | +0.22% | +0.75% |
| 1 month | +3.3% | −2.3% |
| 6 months | +65.4% | +38.2% |
| Year to date | +20.2% | +26.4% |
| 1 year | +53.4% | +52.9% |
| Revenue growth (YoY) | +8.7% | +37.7% |
| Gross margin | 32.9% | 93.7% |
| Net margin | 5.9% | 35.0% |
| P/E (TTM) | 32.4× | 15.7× |
| Price / sales | 2.6× | 4.3× |
| Net cash | -$13.92B | $4.50B |
| Dividend yield | — | — |
| Volatility (60d) | 37.8% | 30.4% |
| Short % of float | 2.8% | 6.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).